Multivariate Cox analysis on the tumors demonstrated that increased YAP1 expression and decreased Lats1 immunoreactivity are associated with worse prognoses in RCC patients and decreased survival [30]. The gene discussed is YAP1; the disease is renal cell carcinoma.